Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Moritz Becher

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Cardiovascular Research|February 12, 2022
Global burden of heart failure: a comprehensive and updated review of epidemiologyGianluigi Savarese, Peter Moritz Becher, Lars H Lund, et al.
Plos One|March 15, 2018
Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factorPeter Moritz Becher, Svenja Hinrichs, Nina Fluschnik, et al.
Plos One|May 18, 2018
Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart diseaseNina Fluschnik, Francisco Ojeda, Tanja Zeller, et al.
Journal of Cardiovascular Development and Disease|November 25, 2021
Differences in the Treatment of Acute Coronary Syndrome in the Pre-COVID and COVID Era: An Analysis from Two German High-Volume CentersDennis Eckner, Eva M Hofmann, Fadil Ademaj, et al.
Basic Research in Cardiology|November 3, 2012
Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivoDirk Westermann, Peter Moritz Becher, Diana Lindner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 12, 2022
Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019Peter Moritz Becher, Alina Goßling, Nina Fluschnik, et al.
Circulation. Heart Failure|December 5, 2013
Interleukin-23 deficiency leads to impaired wound healing and adverse prognosis after myocardial infarctionKonstantinos Savvatis, Kathleen Pappritz, Peter Moritz Becher, et al.
Critical Care (London, England)|September 7, 2021
Seasonal trends of incidence and outcomes of cardiogenic shock : findings from a large, nationwide inpatients sample with 441,696 casesPeter Moritz Becher, Benedikt Schrage, Alina Goßling, et al.
The Journal of Invasive Cardiology|January 1, 2021
Intravascular Lithotripsy for the Treatment of Calcium-Mediated Coronary In-Stent RestenosesFabian J Brunner, Peter Moritz Becher, Christoph Waldeyer, et al.
JACC. Cardiovascular Interventions|October 30, 2024
Percutaneous Coronary Interventions Using Calcium Modification and Intravascular Imaging: Temporal Trends Over The Last DecadeFabian J Brunner, Peter Moritz Becher, Marko Remmel, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Cardiovascular Research|February 12, 2022
Global burden of heart failure: a comprehensive and updated review of epidemiologyGianluigi Savarese, Peter Moritz Becher, Lars H Lund, et al.
Plos One|March 15, 2018
Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factorPeter Moritz Becher, Svenja Hinrichs, Nina Fluschnik, et al.
Plos One|May 18, 2018
Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart diseaseNina Fluschnik, Francisco Ojeda, Tanja Zeller, et al.
Journal of Cardiovascular Development and Disease|November 25, 2021
Differences in the Treatment of Acute Coronary Syndrome in the Pre-COVID and COVID Era: An Analysis from Two German High-Volume CentersDennis Eckner, Eva M Hofmann, Fadil Ademaj, et al.
Basic Research in Cardiology|November 3, 2012
Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivoDirk Westermann, Peter Moritz Becher, Diana Lindner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 12, 2022
Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019Peter Moritz Becher, Alina Goßling, Nina Fluschnik, et al.
Circulation. Heart Failure|December 5, 2013
Interleukin-23 deficiency leads to impaired wound healing and adverse prognosis after myocardial infarctionKonstantinos Savvatis, Kathleen Pappritz, Peter Moritz Becher, et al.
Critical Care (London, England)|September 7, 2021
Seasonal trends of incidence and outcomes of cardiogenic shock : findings from a large, nationwide inpatients sample with 441,696 casesPeter Moritz Becher, Benedikt Schrage, Alina Goßling, et al.
The Journal of Invasive Cardiology|January 1, 2021
Intravascular Lithotripsy for the Treatment of Calcium-Mediated Coronary In-Stent RestenosesFabian J Brunner, Peter Moritz Becher, Christoph Waldeyer, et al.
JACC. Cardiovascular Interventions|October 30, 2024
Percutaneous Coronary Interventions Using Calcium Modification and Intravascular Imaging: Temporal Trends Over The Last DecadeFabian J Brunner, Peter Moritz Becher, Marko Remmel, et al.
Pageof 7